Skip to main content
. 2021 Jan 28;11:538333. doi: 10.3389/fpsyt.2020.538333

Table 1.

Demographic and clinical characteristic of MDD and HC.

MDD HCs (M ± SD)
Pretreatment
(M ± SD)
Posttreatment (M ± SD)
Male/Female 8/11 - 9/8
Age 31.95 ± 9.13 - 30.47 ± 8.50
Education 12.00 ± 3.38 - 11.76 ± 1.56
HAMD-17 21.37 ± 3.08***### 7.26 ± 3.02*** 0.76 ± 0.66
Onset Age 30.58 ± 9.31
DST 14.63 ± 2.36 14.63 ± 1.80 14.76 ± 2.08
SVFT 16.58 ± 4.22*# 18.16 ± 3.27 19.71 ± 4.27
SCWT
   Errors 0.95 ± 1.35*# 0.32 ± 0.75 0.18 ± 0.728
   RRT 14.74 ± 5.89 14.89 ± 7.31 13.88 ± 6.41
WCST
   CC 2.32 ± 2.19# 3.42 ± 2.22 3.18 ± 2.43
   RA 125.21 ± 7.45 123.79 ± 8.97 121.24 ± 10.20
   RC 60.00 ± 18.66## 69.74 ± 20.40 60.18 ± 10.14
   RE 65.21 ± 22.46## 54.05 ± 24.60 55.06 ± 25.15
   PE 49.21 ± 22.17 40.60 ± 26.00 38.41 ± 24.84
   nPE 18.58 ± 5.15 18.58 ± 7.88 16.65 ± 6.06
*

p < 0.05 (MDD vs. HC);

***

p < 0.001 (MDD vs. HC);

#

p < 0.1 (pretreatment vs. posttreatment);

##

p < 0.05 (pretreatment vs. posttreatment);

###

p < 0.001 (pretreatment vs. posttreatment).